BARBOLINI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.420
EU - Europa 1.837
AS - Asia 699
SA - Sud America 95
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
Totale 5.076
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.395
IT - Italia 546
GB - Regno Unito 316
IE - Irlanda 314
SG - Singapore 208
CN - Cina 160
DE - Germania 140
SE - Svezia 139
HK - Hong Kong 112
BR - Brasile 85
RU - Federazione Russa 76
FR - Francia 68
FI - Finlandia 61
ID - Indonesia 44
TR - Turchia 38
UA - Ucraina 28
BE - Belgio 27
JP - Giappone 24
BG - Bulgaria 23
IN - India 23
CA - Canada 21
LT - Lituania 19
NL - Olanda 18
VN - Vietnam 18
TW - Taiwan 16
MY - Malesia 14
IR - Iran 13
CZ - Repubblica Ceca 12
AT - Austria 10
EU - Europa 9
AU - Australia 8
AL - Albania 7
PL - Polonia 6
ES - Italia 5
MT - Malta 5
AR - Argentina 4
CR - Costa Rica 3
GR - Grecia 3
NO - Norvegia 3
RO - Romania 3
SA - Arabia Saudita 3
BD - Bangladesh 2
EC - Ecuador 2
IQ - Iraq 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
NP - Nepal 1
OM - Oman 1
PK - Pakistan 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZM - Zambia 1
Totale 5.076
Salva come PNG Salva come JPEG
Città #
Santa Clara 380
Dublin 313
Chandler 310
Fairfield 219
Ashburn 170
Southend 150
Singapore 131
Nyköping 112
Woodbridge 112
Hong Kong 106
Ann Arbor 99
Seattle 91
Wilmington 88
London 85
Houston 75
Cambridge 72
Modena 64
Dearborn 59
Helsinki 57
New York 50
Jakarta 41
Beijing 40
Jacksonville 37
Moscow 36
Bologna 34
Fremont 34
Milan 34
San Diego 28
Redwood City 27
Princeton 23
Sofia 23
Brussels 22
Lauterbourg 20
Rome 19
San Giuliano Milanese 19
Shanghai 19
Bremen 17
Dong Ket 17
Reggio Emilia 16
Eugene 15
Los Angeles 15
Parma 15
Council Bluffs 14
Falls Church 14
Portsmouth 14
Munich 12
Paris 12
Düsseldorf 11
New Taipei 11
São Paulo 11
Izmir 10
Nuremberg 9
Brno 8
Caprarola 8
Frankfurt am Main 8
Glasgow 8
Guangzhou 8
Tokyo 8
Toronto 8
Norwalk 7
Santorso 7
Sassuolo 7
Shinjuku 7
Venezia 7
Boardman 6
Castelvetrano 6
Des Moines 6
Florence 6
Genoa 6
Istanbul 6
Vernon 6
Aydin 5
Bomporto 5
Changchun 5
Napoli 5
Ottawa 5
Padova 5
Palermo 5
Savona 5
Taipei 5
Vicenza 5
Amsterdam 4
Bagnara di Romagna 4
Brooklyn 4
Carpi 4
Chicago 4
Dallas 4
Kunming 4
Lüleburgaz 4
Melbourne 4
Mesagne 4
Porto Alegre 4
Rabat 4
Tirana 4
Wandsworth 4
Breganze 3
Bussolengo 3
Chengdu 3
Colombo 3
Coral Springs 3
Totale 3.666
Salva come PNG Salva come JPEG
Nome #
GD2 expression in breast cancer. 330
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 263
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 257
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 250
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 239
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 236
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 235
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 228
A concise review of lenalidomide therapy for follicular lymphoma 216
Breast Location for De Novo Extramedullary Myeloid Sarcoma 204
The evolving role of microsatellite instability in colorectal cancer: A review 201
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 199
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 181
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 168
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 166
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 162
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 162
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 158
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 152
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 148
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 140
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 134
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 126
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. 104
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 91
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 82
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 73
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 68
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 58
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 49
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 35
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 18
Totale 5.133
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.591
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.591
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202076 0 0 0 0 0 0 0 0 0 19 31 26
2020/2021614 57 62 39 79 83 60 19 58 32 42 35 48
2021/2022625 43 79 34 22 27 55 31 38 58 43 113 82
2022/20231.154 84 128 89 80 82 91 26 84 367 32 46 45
2023/2024648 31 35 62 65 61 57 78 62 35 36 64 62
2024/20251.350 58 35 61 119 325 239 131 108 188 86 0 0
Totale 5.133